Brennan Kevin M. sold XLO
January 2, 2026 · Form 4 insider transaction
Brennan Kevin M. sold 1,826 shares of Xilio Therapeutics, Inc. at $0.64 per share, a transaction worth $1.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,826
Price
$0.64
Total value
$1.2K
InsiderBrennan Kevin M.
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 2, 2026
Filing dateJanuary 5, 2026
Shares owned after6,371
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported sale of 1,826 shares occurred automatically in a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 8, 2024 solely to cover tax withholding obligations in connection with the vesting of restricted stock units.